Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rochal Technologies is a U.S. wound-care and skin-care medical technology company focused on developing and commercializing polymer- and antimicrobial-based products for surgical, chronic, and acute wound management. The name "Rochal Technologies" appears to refer to the post-2021 Fort Worth operating entity and R&D organization associated with the historical Rochal Industries business, whose assets and team were integrated with Sanara MedTech. Its work centers on wound cleansers, antimicrobial barrier and skin-protectant products, surgical irrigation solutions, and related biomaterial technologies intended to reduce biofilm, support wound healing, and protect damaged skin. The company has developed FDA-cleared products and product candidates spanning wound gel, skin protectants, antimicrobial cleansers, and surgical solutions. Rochal's core capabilities appear to lie in translational wound-care product development from concept through preclinical, clinical, regulatory, and commercialization support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rochal Technologies.